Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: An observational case-control study

Breast Cancer Research and Treatment

Volumn 137, Issue 2, 2013, Pages 599-607

  Bilinski, K ^a   Boyages, J ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b CANCER INSTITUTE NSW   (Australia)

Author keywords

25 Hydroxyvitamin D; Breast cancer; Case control; Sunlight exposure

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; AGE; ARTICLE; AUSTRALIAN; BODY MASS; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL VARIATION; SUMMER; VITAMIN BLOOD LEVEL; WINTER; AGED; AUSTRALIA; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK; SEASON; SUNLIGHT;

AGED; AUSTRALIA; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; SEASONS; SUNLIGHT; VITAMIN D;

MLCS; MLOWN;

EID: 84879016601     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2381-1     Document Type: Article

References (58)

1. Holick MF (2008) Vitamin D: a D-lightful health perspective. Nutr Rev 66(10 Suppl 2):S182-S194
2. Zerwekh JE (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87(4):1087S-11091
3. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Nutrition Board IoM (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy of Sciences, Washington
4. Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94(1):26-34
5. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2008) Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. Breast J 14(3):255-260
6. Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19(4):820-824
7. Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, Mosekilde L (2009) Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 18(10):2655-2660. doi: 10.1158/1055-9965.EPI-09-0531
8. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14(8):1991-1997
9. Eliassen AH, Spiegelman D, Hollis B, Horst R, Willett W, Hankinson S (2011) Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res 13(3):R50
10. Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD, Ziegler RG (2008) Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 17(4):889-894
11. McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE (2009) Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast cancer research 11(4):R64. doi: 10.1186/bcr2356
12. Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99(21):1594-1602
13. Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19(6):614-622
14. Chen W, Clements M, Rahman B, Zhang S, Qiao Y, Armstrong BK (2010) Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control 21(10):1701-1709. doi: 10.1007/s10552-010-9599-1
15. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011) Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 20(1):187-198
16. Medicine IIo (2011) Dietary reference intakes for calcium and vitamin D. The National Academies, Washington
17. Grant WB (2011) Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinology 3(3):199-204. doi: 10.4161/derm.3.3.15364
18. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, wson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84(1):18-28
19. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16(7):713-716
20. Heaney RP (2008) Optimal Vitamin D Status. J Bone Miner Res 24(4):755
21. Vieth R (2006) What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92(1):26-32
22. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2010) Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 19(9):2341-2350
23. John EM, Schwartz GG, Dreon DM, Koo J (1999) Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 8(5):399-406
24. Bolland MJ, Grey A, Gamble GD, Reid IR (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr. doi: 10.3945/ajcn.111.015032
25. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2010) Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46(12):2196-2205. doi: S0959-8049(10)00280-7
26. Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J (2010) Serum levels of vitamin D, PTH, calcium and breast cancer risk: a prospective nested case-control study. Int J Cancer 127(9):2159-2168
27. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100(22):1581-1591
28. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2(6):598-604
29. Colston KW, Lowe LC, Mansi JL, Campbell MJ (2006) Vitamin D status and breast cancer risk. Anticancer Res 26 (4A):2573-2580
30. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J (2008) Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis 29(1):93-99
31. Abbas S, Chang-Claude J, Linseisen J (2009) Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 124(1):250-255
32. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, Colston KW (2005) Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41(8):1164-1169
33. Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, Saldana-Quiroz VA, Romieu I (2012) Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control 23(7):1149-1162. doi: 10.1007/s10552-012-9984-z
34. Abbas S, Linseisen J, Chang-Claude J (2007) Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study. Nutr Cancer 59(1):54-61
35. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R (2007) Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 16(3):422-429
36. Grant W (2012) Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyitamin D and all-cause mortality rate. Dermatoendocrinology 4(2):198-202
37. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3):690-693
38. Harvie M, Hooper L, Howell AH (2003) Central obesity and breast cancer risk: a systematic review. Obes Rev 4(3):157-173
39. Amir E, Cecchini RS, Ganz PA, Costantino JP, Beddows S, Hood N, Goodwin PJ (2012) 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat 133(3):1077-1088. doi: 10.1007/s10549-012-2012-x
40. Boyages SB, Bilinski K (2012) Seasonal variation in vitamin D persists into spring: Implications for monitoring and replacement therapy. Clin Endocrinol (Oxf.) 77(4):515-523
41. Daly RM, Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Sikaris KA, Zimmet PZ, Ebeling PR, Shaw JE (2011) Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol. doi: 10.1111/j.1365-2265.2011.04320.x
42. Pink B (2006) Information paper: an introduction to Socio-Economic Indexes for Areas (SEIFA). Australian Bureau of Statistics, Canberra
43. Bischoff-Ferrari HA (2008) Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 624:55-71
44. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135(2):317-322
45. Centre NBaOC (2009) Breast cancer risk factors a review of the evidence. National Breast and Ovarian Cancer Centre, Surry Hills SNW 2010
46. WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. WHO, Geneva
47. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27(23):3757-3763
48. Peppone L, Rickles A, Huston A, Sprod L, Hicks D, Mustian K, Skinner K (2011) The association between prognostic demographic and tumor characteristics of breast carcinomas with serum 25-OH vitamin D levels. Cancer Epidemiol Biomarks Prev 20(4):717
49. Colston KW (2008) Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab 22(4):587-599
50. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94(17):1301-1311
51. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM (2007) Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 167(10):1050-1059
52. Lagunova Z, Porojnicu AC, Grant WB, Bruland ò, Moan JE (2010) Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association? Mol Nutr Food Res 54(8):1127-1133
53. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15(3):255-265. doi: 10.1023/B:CACO.0000024245. 24880.8a
54. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM (2012) Accuracy of 6 routine 25-hydroxyvitamin d assays: influence of vitamin D binding protein concentration. Clin Chem 58(3):543-548. doi: 10.1373/clinchem.2011.176545
55. Lai JK, Lucas RM, Banks E, Ponsonby AL (2012) Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 42(1):43-50. doi: 10.1111/j.1445-5994.2011.02471.x
56. Hill A (1965) The environment and disease: association or causation? Proc R Soc Med 58:295-300
57. Grant WB (2009) How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermatoendocrinology 1(1):17-24
58. Mohr SBGE, Alcaraz JE, Kane CI, Macera CA, Parsons JE, Wingard DL, Garland CF (2012) Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? Dermatoendocrinology 4(2):152-157